Adel Mahmoud M.D., Ph.D., is a lecturer with the rank of Professor in Molecular Biology and Public Policy at the Woodrow Wilson School and the Department of Molecular Biology. Mahmoud is the former President of Merck Vaccines and an expert on disease control in the developing world. Mahmoud's research and teaching at the School focuses on medical and policy issues related to global health. Mahmoud's research focuses on two areas related to global infection. The first involves examination of causes of emergence and re-emergence of microorganisms and examination of strategies for controlling infectious disease at the national and global levels including chemotherapy, vaccines and community containment. The second major area of investigations involves discovery, development and global deployment and use of vaccines. At Merck, Mahmoud has been involved in the development of four new vaccines. These include vaccines for infection with rotavirus, human papillomavirus, shingles and combination of measles, mumps, rubella and varicella. M.D. University of Cairo, D.P.H. University of Ain Shams. Ph.D. University of London.